GlassScriptPhysician profile
Mary Mccoy
NPI 1306841069
$1,324.97
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,053 · 2020: $204 · 2021: $20.43 · 2022: $48.12.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $330.59 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $264.99 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $139.99 | 2019-2020 | |
| Advanced Respiratory, INC | $111.58 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $109.20 | 2019-2020 | |
| Pfizer INC. | $88.53 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $37.49 | 2019 | |
| Astellas Pharma US INC | $35.50 | 2019-2020 | |
| Lilly USA, LLC | $27.48 | 2019-2020 | |
| Radius Health, INC. | $26.14 | 2019 | |
| Boston Scientific Corporation | $25.99 | 2022 | |
| Amgen INC. | $25.80 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $24.30 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.22 | 2019 | |
| Abbvie INC. | $19.08 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.80 | 2019 | |
| Avanir Pharmaceuticals, INC. | $11.95 | 2019 | |
| Circassia INC. | $11.34 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Mccoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.